The NZD10M pathway to a NZ Stock Exchange Listing.
Seed Capital, "job done"
Series B-US Distribution
Seed Capital, "job done"
Between 2016 and 2023, USD387k (NZD650k) in seed capital was invested in developing the NZ-US cross-border ecosystem required to support the NZ "Seed-to-Ship" Natural Health Product ("NHP") supply system plus the "Ship-to-Shelf" distribution ecosystem.
Series A-NZ Production
Series B-US Distribution
Seed Capital, "job done"
Our pathway to listing commences upon closing the NZD2M (USD1.2M) Series A Round which enables the full launch of the NZ extraction ops launch and shipment of first 20,000 SKU's to the US distribution hub.
Series B-US Distribution
Series B-US Distribution
Series B-Australia GMP facilities
NZD2.5M of the USD5M (NZD8M) Series B has been allocated to purchase of a Related Affiliate Corp in the US that operates an NHP distribution facility based in Valencia, CA. In operation for 14 years with an established NHP retail B2B customer base across the US.
Series B-Australia GMP facilities
Series B-Australia GMP facilities
Series B-Australia GMP facilities
NZD2.5M of the USD5M (NZD8M) Series B has been allocated to the purchase of a TGA / GMP compliant therapeutic products manufacturing facility in northern NSW.
Series B-NZ Production facility
Series B-Australia GMP facilities
Series B-NZ Production facility
NZD3M has been allocated to the relocation of the extraction ops to a high profile, main highway site where the oil operations are planned to be interfaced into a tourism focused destination.
Series C-NZD239M Market Cap?
Series B-Australia GMP facilities
Series B-NZ Production facility
The successful closing of the Series A and B Rounds and their application to an investment into a profitable, going concern NHP operation in NZ, AU and the US, facilitates an application to list on the NZ Stock Exchange via IPO.
Yes. NZD10M can launch a NZD1B+ NZ tea tree sector.
In the "Triple K" triangle, one station alone has over NZD100M worth of unharvested NZ tea tree oil.
This therapeutic grade NZ tea tree oil will deliver.
NZ manuka & kanuka oil are efficacious as natural infection control remedies. Interestingly, kanuka oil wins in nosocomial infection protection.
With gender-specificity creating unique value adding.
And don't forget that circa 85% of the NZ tea tree resource is on customary tribal lands. So give the owners a fair go with resource extraction putea.
Your "Tribal" investment DD pathway starts here.
DOC-1880R
DOC-1880R
DOC-1880R
There is no rocket science behind listing on the NZX. In just 7 pages, we illustrate the "7 Steps" to IPO and listing in one year. Doable!
DOC-1881R
DOC-1880R
DOC-1880R
This 24 page brochure describes our NZD6.6M Series A and NZD10M Series B Rounds that will take us to listing.
DOC-1882
DOC-1880R
DOC-1882
This is our 15 page "Pitch Deck". A slide show that pictorially illustrates our business pathway from seed to listing.
DOC-1883
DOC-1883
DOC-1882
Our 68 page, NZD6.6M Series A Round "Private Placement Memorandum" using the NASAA, Form U7 disclosure template.
DOC-1884
DOC-1883
DOC-1884
This is an abridged version of Form U7, issued to support the provisionally subscribed NZD10M Series B Round for the AU-US ops.
DOC-1888
DOC-1883
DOC-1884
An 8 page, Expression of Interest for Angel Investors to meet the Pre-Series A & B costs and provide an independent director.
Join the growing tide of Americans investing in NZ!
Enjoy "Endless Summer" investments in 3 countries.